CompanyGraphWhat stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- PositionOperating margin is 42.2%, higher than 95% of its Biotechnology peers (median -38%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
1.40TKRW1.01B · vs all stocks (USD)
Revenue (TTM)
66.79BKRW48.12M · vs all stocks (USD)
Profit Margin
57.79%vs Biotechnology peers
52-Week Change
-50.57%vs all stocks
Market Capitalization
1.40TKRW1.01B · vs all stocks (USD)
Enterprise Value
1.32TKRW947.76M · vs all stocks (USD)
Forward P/E
156.47xvs Biotechnology peers
Price to Sales (TTM)
20.89xvs Biotechnology peers
Enterprise to Revenue
19.70xvs Biotechnology peers
Enterprise to EBITDA
50.94xvs Biotechnology peers
Profit Margin
57.79%vs Biotechnology peers
Operating Margin
42.19%vs Biotechnology peers
Return on Assets (TTM)
9.85%vs Biotechnology peers
Return on Equity (TTM)
25.93%vs Biotechnology peers
Revenue (TTM)
66.79BKRW48.12M · vs all stocks (USD)
Revenue per Share (TTM)
1.10KKRWUpdated Sep 19, 2026Quarterly Revenue Growth
165.60%vs Biotechnology peers
Gross Profit (TTM)
66.79BKRW48.12M · vs all stocks (USD)
EBITDA (TTM)
25.83BKRW18.61M · vs all stocks (USD)
Net Income (TTM)
38.60BKRW27.81M · vs all stocks (USD)
Operating Cash Flow (TTM)
10.78BKRW7.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-867.23MKRW-624.80K · vs all stocks (USD)
Shares Outstanding
64.16MSharesUpdated Sep 19, 2026Float Shares
22.61MSharesUpdated Sep 19, 2026% Held by Insiders
40.45%vs all stocks
% Held by Institutions
15.85%vs all stocks
Total Cash (MRQ)
92.67BKRW66.76M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.43KKRWUpdated Sep 19, 2026Total Debt (MRQ)
1.57BKRW1.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0077xvs Biotechnology peers
Current Ratio (MRQ)
17.33xvs Biotechnology peers
52-Week Low
17.40KKRWUpdated Sep 19, 202652-Week High
80.20KKRWUpdated Sep 19, 202652-Week Change
-50.57%vs all stocks
50-Day MA
23.40KKRWUpdated Sep 19, 2026200-Day MA
41.80KKRWUpdated Sep 19, 2026Avg 10-Day Volume
86.73KSharesUpdated Sep 19, 2026Avg 30-Day Volume
108.23KSharesUpdated Sep 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 42.2%, higher than 95% of its Biotechnology peers (median -38%)Significant
Operating margin: 0.42Industry median: -0.38Industry P95: 0.40Peers compared: 260
Profit margin is 57.8%, higher than 95% of its Biotechnology peers (median -47.7%)Significant
Profit margin: 0.58Industry median: -0.48Industry P95: 0.42Peers compared: 260
Return on equity is 25.9%, higher than 95% of its Biotechnology peers (median -22.3%)Significant
Return on equity: 0.26Industry median: -0.22Industry P95: 0.23Peers compared: 260
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 27,806,610.481Operating Cash Flow (USD, TTM): 7,764,361.165
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Monte Rosa Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sunflower Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Blue Jet Healthcare Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sino Medical Sciences Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pacira BioSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghua Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Janux Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Dezhan Health Care Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated